Trends & Forecasts

From wearable health tech to telehealth, here’s how digital transformation could impact the pharma industry and patient access.

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

How will digitalization and automation redefine pharma manufacturing in the next decade?

Takeda experts explore the potential of AI-driven drug discovery and the importance of including diverse patient voices in trial design.

Colleen Dixon and Mary Glotzbach discuss key areas for improvement, including automation, eco-friendly practices, and patient-centric delivery methods

Step into a future where science fiction meets reality – the world of cell and gene therapies.

How immunotherapy could redefine cancer treatment.

Regeneron’s Gary Herman discusses the future of genetic medicines and the role of new delivery systems.

The 2024 Access to Medicine Index has a new leader, but analysts are concerned about stakeholder commitment.

Controversial and divisive, but Kennedy’s expertise is intended for one thing: change.